Introduction {#sec1-1}
============

Depression is a chronic, recurrent psychiatric disorder affecting nearly 21% of the world\'s population.\[[@ref1][@ref2]\] According to the World Health Organization reports, it will become the fourth leading cause of disability worldwide by the year 2020.\[[@ref3][@ref4]\] The monoaminergic theory states that depletion of brain neurotransmitters such as 5-hydroxytyrptamine (5-HT), norepinephrine (NE), and dopamine (DA) assumes to play a key role in the pathophysiology of depression.\[[@ref5]\] Clinically, at the early stages of depression, noradrenaline reuptake inhibitors (e.g., desipramine and reboxetine) and selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine and citalopram) have been mainly exploited for the monotherapy treatment.\[[@ref6]\] However, as the monotherapy ended up with the emergence of resistance to treatment in many patients, inevitably, the combined use of antidepressant drugs with different mechanism becomes an advanced option for the patient\'s resistance to monotherapy treatment.\[[@ref7][@ref8]\] However, the combination of SSRIs with tricyclic antidepressants (TCAs) has been reported to show the drug--drug interactions and undesirable side effects, which may limit the use of the most preferred TCA--SSRI combination.\[[@ref9]\] Hence, there is a necessity to develop the newer antidepressant drugs with more safety and efficacy. Medicinal plants could be considered an excellent source for the antidepressant novel drug discovery by virtue of its proven safety and presence of multiple phytoconstituents which may exert synergistic effects. Recently, medicinal plants have been explored as complementary and alternative medicine for the treatment of depression.\[[@ref10][@ref11]\]

*Asparagus adscendens* Roxb. (Liliaceae), commonly known as safed musali or dholi musali, is a climbing herb found mainly in Asian countries.\[[@ref12]\] Its medicinal uses have been well documented in various traditional records as an aphrodisiac and brain tonic.\[[@ref13][@ref14]\] Literature reveal that roots of *A. adscendens* have been investigated for antifilarial,\[[@ref15]\] antidiabetic,\[[@ref16]\] antistress,\[[@ref17]\] chemomodulatory,\[[@ref18]\] aphrodisiac,\[[@ref19]\] antifungal,\[[@ref20]\] and antioxidant activities.\[[@ref18][@ref21][@ref22]\] Pertaining to the phytochemical analysis, several studies showed the presence of 3-heptadecanone, 3-hexadecenoic acid, methyl pentacosanoate, tetratriacontane, tritriacontane, methyl palmitate, tetracosyl tetracosanoate, palmitic acid, stearic acid, asparanin C, asparanin D, asparoside C, asparoside D, 3-β-O-(β-D-2-tetracosylxylopyranosyl) -stigmasterol, 3-β-O-(β-D-glucopyranosyl (1-2)-α-L-arabinopyranosyl)-stigmasterol, β-sitosterol-β-D-glucoside, Vitamin C, xanthophylls, Vitamin E, β-carotene, and Shatavarin IV.\[[@ref23][@ref24][@ref25][@ref26][@ref27][@ref28]\] Moreover, clinically, *A. adscendens* has been used for the treatment of depression and other neurological disorders, as an ingredient in one of the famous pharmaceutical formulations (Geriforte).\[[@ref29][@ref30]\] Despite being a part of clinically used formulation, the *A. adscendens* *per se* has never been evaluated for the treatment of depression. Furthermore, earlier studies suggested that many medicinal plants possessing aphrodisiac and antioxidant potential have been found to possess antidepressant activity also.\[[@ref18][@ref31][@ref32]\] Hence, the current study was envisaged to explore the antidepressant effect of root extract of *A. adscendens* and its possible mechanisms.

Materials and Methods {#sec1-2}
=====================

Drugs and chemicals {#sec2-1}
-------------------

All standard chemicals used in this study were of analytical grade. Shatavarin IV was procured from Natural Remedies Pvt. Ltd., Bengaluru, India. Serotonin, DA, NE, and Griess reagent were procured from Sigma-Aldrich, Co., St. Louis, MO, USA. Imipramine was obtained from Troikaa Pharmaceuticals, Dehradun, Uttarakhand, India.

Animals {#sec2-2}
-------

Swiss Albino mice of either sex weighing 20--30 g (3--4 months of age) were purchased from Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar, Haryana. The animals were housed on a 12-h light/dark cycle under controlled temperature (22°C ± 2°C) and humidity (50 ± 10%). They were allowed to acclimate for 1 week with access to food and water ad libitum. The procedures in this study were conducted in accordance to the guidelines of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Environment and Forest, Government of India, and approved by the Institutional Animal Ethical Committee (107/99/CPCSEA-2016-13).

Plant collection and preparation of extract {#sec2-3}
-------------------------------------------

Roots of *A. adscendens* were procured from "Council of Scientific and Industrial Research -Institute of Himalayan Bioresource Technology" (CSIR-IHBT), Palampur (Himachal Pradesh), India, and authenticated by Dr. Bikram Singh (CSIR-IHBT), Palampur (Himachal Pradesh) in May--June, 2013 (Voucher no. PLP16565). The authenticated roots were washed with water, shade-dried, and ground to a moderately coarse powder. The powdered roots were subjected to extraction by percolation method with ethanol: water (50:50 v/v) at room temperature. The resultant extract was evaporated to dryness using a rotary evaporator (Buchi Type Rotary Vacuum Evaporator, Axiva, Shanghai, China) followed by lyophilization (Delvac, Chennai, Tamilnadu, India) and stored at 4°C for further use. The percentage yield of the extract was found to be 44.7% w/w.

Phytochemical analysis and standardization of the plant extract using high-performance-thin-layer chromatography {#sec2-4}
----------------------------------------------------------------------------------------------------------------

*A. adscendens* extract (AAE) was subjected to preliminary phytochemical screening tests to determine the presence of alkaloids, carbohydrates, glycosides, saponins, steroids, triterpenoids, flavonoids, tannins, proteins, and amino acids.\[[@ref33]\]

Shatavarin IV being one of the constituents present in *A. adscendens* was used as a biomarker for the standardization of the hydroethanolic extract. The presence of Shatavarin IV in the hydroethanolic extract was confirmed by using high-performance-thin-layer chromatography (HPTLC) method as reported by Gohel *et al*.\[[@ref34]\] Initially, the presence of Shatavarin IV was confirmed by TLC using ethyl acetate: methanol: water (7.5:1.5:0.5, v/v/v) as a mobile phase. The plate was derivatized by spraying with freshly prepared anisaldehyde in sulfuric acid and then dried in an oven at 100°C for 10 min. Further, *A. adscendens* was standardized with Shatavarin IV using HPTLC. A stock solution of hydroethanolic extract (30 mg/mL) and Shatavarin IV (1 mg/mL) was prepared in methanol. The mobile phase and spraying reagent for developing the chromatogram were same as that used in TLC. Detection was done by the measurement of absorbance at 426 nm. The study was carried out using precoated silica gel aluminum plate 60F~254~(20 cm × 20 cm, E. Merck, Germany); Camag-HPTLC instrumentation (Camag, Muttenz, Switzerland) equipped with Camag Linomat V sample applicator, Camag TLC scanner IV and CAMAG Win CATS (1.4.8.2031, Camag, Muttenz, Switzerland) for data interpretation. The *R*~f~ values were recorded, and the developed plate was screened at a wavelength (λ~max~) of 426 nm. Standard curve was prepared with Shatavarin IV (*y* = 2.239x + 712.7) with a regression coefficient (*R*^2^) of 0.997.

Acute toxicity test of the extract {#sec2-5}
----------------------------------

The AAE was administered to six different groups of mice (*n* = 6) at different doses, up to ten times of effective dose, i.e., 25, 50, and 100 mg/kg; i.p. One group served as vehicle control and received equal volume of vehicle. Percentage mortality and gross behavioral changes were observed during 24 h after treatment.\[[@ref35][@ref36]\]

Experimental protocol {#sec2-6}
---------------------

Six groups of animals (*n* = 6) were investigated. Group I: naive (incorporated for the biochemical studies only); Group II: saline (vehicle control) (10 mL/kg/day, i.p.); Group III: imipramine (standard drug) (15 mg/kg/day, i.p.);\[[@ref10]\] Groups IV, V, and VI: AAE(25, 50, and 100 mg/kg/day, i.p., respectively) (based on the results of pilot studies carried out on limited number of animals, three doses were selected for the current study). AAE and imipramine were dissolved in normal saline. The animals were treated for 14 days with respective treatments. The behavioral assessment was made after half an hour of AAE (25, 50, and 100 mg/kg) and imipramine (15 mg/kg) administration on 14^th^ day. The animals were sacrificed by decapitation, and their brains were removed after behavioral assessments. The regions of brain (cortex and hippocampus) were isolated immediately and then stored at − 80°C for later analysis. The blood was immediately collected, separated, and centrifuged at 4°C. Serum was stored at − 20°C until assay was performed.

Behavioral assessments {#sec2-7}
----------------------

### Forced swimming test {#sec3-1}

The modified forced swimming test (FST) was conducted on the mice as reported previously,\[[@ref37][@ref38]\] with slight modification. Briefly, mice were individually placed in a glass cylinder (25 cm in height, 14 cm in diameter) filled with 20-cm high water (25°C ± 2°C), and the duration of immobility was observed for 6 min (out of which 2 min is for habituation). The test session was recorded by a video camera and scored by a blind observer. During the test session, some behavioral parameters were recorded in seconds such as immobility time (i.e., cessation of limb movement necessary to keep the mouse afloat), climbing time (i.e., upward directed movements of the forepaws along the side of the swim chamber), and swimming time (i.e., movement usually horizontal throughout the swim chamber).

### Tail suspension test {#sec3-2}

The tail suspension test (TST) was conducted as previously described,\[[@ref37][@ref39]\] with some modifications. Briefly, mice were individually suspended by tail with a clamp (1 cm from the tip of the tail). Testing was carried out in a noise-free room. A mouse was suspended for a total of 6 min, and the duration of immobility was recorded during the final 4-min interval of the test. Mice were considered immobile only when they hung passively and completely motionless. The test session was recorded by a video camera and scored by a blind observer.

Open-field test {#sec2-8}
---------------

To assess the possible effects of the extract on locomotor and exploratory behaviors, mice were individually evaluated in the open field paradigm.\[[@ref9][@ref40]\] The apparatus consisted of a wooden box measuring 40 cm × 40 cm × 30 cm, with the floor divided into 25 equal squares (8 cm × 8 cm). The number of squares crossed with all paws (crossings) and of standing on the hind legs (rearing) was observed for 5 min after 1 min acclimatization in each session. The apparatus was cleaned with 10% alcohol to prevent auditory cue. The test session was recorded by a video camera and scored by a blind observer.

Estimation of monoamines using high-performance liquid chromatography with electrochemical detection {#sec2-9}
----------------------------------------------------------------------------------------------------

The levels of brain monoamine neurotransmitters were measured by high-performance liquid chromatography with electrochemical detection (Zapata *et al*., 2009, with slight modification).\[[@ref41]\] Briefly, the brain samples were homogenized in an ice-cold solution of 0.1 M perchloric acid and then centrifuged at 14,500 g for 30 min at 4°C. The clear supernatants were filtered through a 0.45-μm pore membrane. Standard solution or samples were injected into the column (5 μm, 250 mm × 4.6 mm). The separation was done in an isocratic elution mode at a column temperature of 35°C using mobile phase consisting of 0.15 M sodium dihydrogen phosphate, 2.28 mM heptane sulphonic acid, and 1 mM ethylenediaminetetraacetic acid (pH 5.4), containing 10% methanol at a flow rate of 0.9 mL/min. The contents of monoamine neurotransmitters were expressed in ng/g wet weight tissue.\[[@ref42]\] The order of elution of monoamines in the chromatogram was norepineprine (6.481 min), DA (15.437 min), and 5-HT (38.144 min). The amount of monoamines in standard and samples was quantified using area under the curve of the corresponding sample using their straight line equation: NE (*y* = 13363x − 12625; *R*^2^= 0.998); DA (*y* = 45909x − 26031; *R*^2^= 0.997); and 5-HT (*y* = 55131x + 38031; *R*^2^= 0.998).

Biochemical estimation {#sec2-10}
----------------------

The brain samples were homogenized in an ice-cold 10% w/v (0.05 M, pH 7.4) phosphate buffer and then centrifuged at 6000 g for 20 min at 4°C. The clear supernatant obtained was used for the estimation of thiobarbituric acid-reactive substances (TBARS), reduced glutathione (GSH), catalase (CAT), and total nitrite levels.

Estimation of thiobarbituric acid-reactive substance {#sec2-11}
----------------------------------------------------

The quantitative measurement of TBARS, an index of lipid peroxidation, was performed using the method described by Oakes and Van der Kraak with slight modifications. The absorbance was measured at 532 nm using a microplate reader (BIORAD-Microplate Reader, Logotech, ISE Group, Germany). A standard calibration curve was prepared using 1--10 nM of 1,1,3,3-tetra methoxy propane (*y* = 0.0105x + 0.0562; *R*^2^= 0.992). TBARS value was expressed as nanomoles/mg of protein.\[[@ref43]\]

Estimation of reduced glutathione {#sec2-12}
---------------------------------

The reduced GSH content in the brain was estimated by using the method described by Beutler *et al*. with slight modifications. Absorbance was measured using a microplate reader (BIORAD-Microplate Reader, Logotech, ISE Group, Germany) at 412 nm. Reduced GSH standard curve was plotted using a 10--100 μM of reduced GSH. The results were calculated using the following equation: *y* = 0.001x + 0.085; *R*^2^= 0.994. All the values were expressed as micromoles per gram of wet tissue.\[[@ref44]\]

Estimation of catalase {#sec2-13}
----------------------

CAT activity was determined by using the modified method of Chance and Maehly CAT activity was calculated by using the molar extinction coefficient of H~2~O~2~(0.071 mM/cm) and was expressed as micromoles of H~2~O~2~ oxidized per minute per milligram protein.\[[@ref45]\]

Estimation of total nitrite level {#sec2-14}
---------------------------------

The total nitrite level was estimated employing the method described by Choudhary *et al*. Absorbance was noted using a microplate reader (BIORAD-Microplate Reader, Logotech, ISE Group, Germany) at 540 nm. The standard curve was plotted using 10--100 mM of sodium nitrite. The results were calculated using the following equation: *y* = 0.0472x + 0.1034; *R*^2^= 0.9982). All the values were expressed as ng/g of wet tissue.\[[@ref46]\]

Serum corticosterone measurement {#sec2-15}
--------------------------------

The corticosterone level was assessed by employing the modified method described by Kumar *et al*. and Lim *et al*. using spectrofluorometer (Perkin Elmer, US) at 475 nm excitation and 525 nm emissions. The standard curve was plotted using 10--100 ng of corticosterone. The results were calculated using the following equation: *y* = 0.785x + 8.777; *R*^2^= 0.992). All the values were expressed as ng/mL.\[[@ref47][@ref48]\]

Statistical analysis {#sec2-16}
--------------------

Statistical analysis of significance was carried out by using one-way analysis of variance (ANOVA) followed by Student--Newman--Keuls *post hoc* multiple comparison test using GraphPad prism^®^ version 5 (Graph-Pad Software Inc., San Diego, CA, USA).

Results {#sec1-3}
=======

Phytochemical analysis and standardization of plant extract {#sec2-17}
-----------------------------------------------------------

Preliminary phytochemical screening confirmed the presence of carbohydrates, glycosides, flavanoid, saponins, steroids, triterpenoids, and amino acids in the hydroethanolic extract. The HPTLC analysis depicted well-resolved peaks of *A. adscendens* showing the presence of Shatavarin IV. The spots of the entire chromatogram were visualized at 426 nm, and the quantity of Shatavarin IV was found to be 9.4 mg/kg of the hydroethanolic extract \[Supplementary Figure 1A and B\].

Acute toxicity studies {#sec2-18}
----------------------

In acute toxicity test, no mortality was observed in animals treated with the extract at all doses. There was no change in the behavior of animals during 24 h of administration of the extract. The extract was found to have no neurotoxic effects with respect to disturbances in motor coordination up to the highest dose (i.e., 100 mg/kg).

Effect of *Asparagus adscendens* extract on forced swimming test {#sec2-19}
----------------------------------------------------------------

The results illustrated in [Figure 1A](#F1){ref-type="fig"} show the effect of AAE on the duration of immobility time in the FST model. One-way ANOVA revealed that there were significant differences between the treatment groups (F~4,25~\]= 20.03, *P* \< 0.0001). Student--Newman--Keuls test showed that AAE (25, 50, and 100 mg/kg) significantly decreased the duration of immobility time as compared to vehicle control group.

![Effect of *Asparagus adscendens* extract treatment on the behaviors in mice. Immobility (panel A), swimming (panel B), and climbing (panel C) time in the modified forced swimming test. Immobility time (panel D) in the tail suspension test. Crossing (panel E) and rearing (panel F) numbers in the open-field test. Values were expressed as mean ± standard error of the mean. The significance level was considered as *P*\< 0.05 (Student--Newman--Keuls test) \* = As compared with naïve animals. IMP 15 = Imipramine 15 mg/kg; i.p. AAE 25, 50, and 100 =*Asparagus adscendens* extract 25, 50, and 100 mg/kg; i.p., respectively](IJPharm-51-98-g001){#F1}

Treatment with AAE revealed the significant effect on the swimming time in the modified FST (F~4,25\]~= 8.956, *P* \< 0.0001). The extract significantly increased the swimming time at 50 and 100 mg/kg as compared to vehicle control group \[[Figure 1B](#F1){ref-type="fig"}\]. Moreover, imipramine also elicited the swimming time after administration of 15 mg/kg dose.

A significant effect of the treatment on the climbing time was seen in modified FST \[[Figure 1C](#F1){ref-type="fig"}\]. AAE significantly increased the climbing time at 50 and 100 mg/kg when compared to vehicle control group (F~4,25\]~= 6.637, *P* = 0.0009). Similarly, imipramine also increased the climbing time in the test.

Effect of *Asparagus adscendens* extract on tail suspension test {#sec2-20}
----------------------------------------------------------------

The results illustrated in [Figure 1D](#F1){ref-type="fig"} show the effect of AAE on the duration of immobility time in the tail suspension model. One-way ANOVA revealed a significant effect of the treatment on the immobility time in the TST (F~4,25\]~= 8.817, *P* = 0.0001). Student--Newman--Keuls test indicated a significant decrease in the immobility time attenuated by the administration of AAE at 50 and 100 mg/kg. Moreover, imipramine also decreased the immobility time after administration of 15 mg/kg dose.

Effect of *Asparagus adscendens* extract on open-field test {#sec2-21}
-----------------------------------------------------------

No significant effect of the AAE treatment (25, 50, and 100 mg/kg) was observed on the number of crossing \[[Figure 1E](#F1){ref-type="fig"}\] and rearing \[[Figure 1F](#F1){ref-type="fig"}\] as compared to that of the vehicle control group in this test.

Effect of *Asparagus adscendens* extract on monoamine neurotransmitters levels in cortical and hippocampal areas of mouse brain {#sec2-22}
-------------------------------------------------------------------------------------------------------------------------------

### Changes in norepinephrine levels {#sec3-3}

A significant difference observed in the concentration of NE in both cortical (F~5,30\]~= 17.48, *P* \< 0.0001) and hippocampal (F~5,30)~= 9.479, *P* \< 0.0001) areas in between the groups \[[Figure 2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}\]. Student--Newman--Keuls test indicated a significant decrease in the cortical and hippocampal NE levels of vehicle control as compared to naive group. However, a significant increase in cortical and hippocampal NE levels was observed in AAE-treated animals, whereas no significant change was observed in imipramine-treated group as compared to vehicle control group. Moreover, the cortical and hippocampal NE levels increased significantly only at AAE (100 mg/kg) dose as compared to vehicle control group.

![Effect of *Asparagus adscendens* extract treatment on monoamine neurotransmitters. Norepinephrine level cortex (panel A) and hippocampus (panel B); Dopamine level cortex (panel C) and hippocampus (panel D); 5-hydroxytyrptamine level cortex (panel E); and hippocampus (panel F) in (ng/g of wet tissue). Values were expressed as mean ± standard error of the mean. The significance level was considered as *P*\< 0.05 (Student--Newman--Keuls test) \* = As compared with naïve; \# = As compared with vehicle control; IMP 15 = Imipramine 15 mg/kg; i.p. AAE 25, 50, and 100 =*Asparagus adscendens* extract 25, 50, and 100 mg/kg; i.p., respectively](IJPharm-51-98-g002){#F2}

### Changes in dopamine levels {#sec3-4}

There was a significant difference between the groups in the concentration of DA in cortical (F~5,30\]~= 25.78, *P* \< 0.0001) and hippocampal (F~5,30\]~= 38. 47, *P* \< 0.0001) areas in between the groups. Student--Newman--Keuls test suggested a significant decrease in cortical and hippocampal DA levels of vehicle control as compared to naive group. However, a significant increase was observed in the cortical and hippocampal DA levels of AAE-treated groups as compared to vehicle control group. Moreover, no significant change in DA level was recorded in imipramine-treated group as compared to vehicle control group \[[Figure 2C](#F2){ref-type="fig"} and [D](#F2){ref-type="fig"}\].

### Changes in serotonin levels {#sec3-5}

There was a statistically significant difference in the concentration of serotonin in the cortex (F~5,30\]~= 9.044, *P* \< 0.0001), whereas no significant change was observed in hippocampal serotonin level in between the groups. Student--Newman--Keuls test revealed a significant decrease in cortical serotonin level of vehicle control as compared to naive group. However, a significant increase was observed in cortical serotonin level of AAE-treated groups as compared to vehicle control group. Moreover, no significant change in serotonin level was recorded compared in imipramine-treated group to vehicle control group \[[Figure 2E](#F2){ref-type="fig"} and [F](#F2){ref-type="fig"}\].

### Effect of *Asparagus adscendens* extract on lipid peroxidation, reduced glutathione, catalase, and total nitrite levels in cortical and hippocampal areas of mouse brain {#sec3-6}

There was a significant difference in lipid peroxidation level in the cortical (F~5,30\]~= 22.65, *P* \< 0.0001) and hippocampal (F~5,30\]~= 17.86, *P* \< 0.0001) areas in between the groups. Student--Newman--Keuls test suggested a significant increase in the cortical and hippocampal lipid peroxidation levels of vehicle control as compared to naive group. However, a significant decrease was observed in cortical and hippocampal lipid peroxidation levels of AAE-treated group as compared to vehicle control group. Similarly, a significant decrease in cortical and hippocampal lipid peroxidation levels was observed in imipramine-treated group as compared to vehicle control group \[[Table 1](#T1){ref-type="table"}\].

###### 

Effect of *Asparagus adscendens* extract treatment on oxidative parameters in the cortex and hippocampus

  Treatment          TBARS (nmol/mg protein)   Reduced GSH (µmol/g of wet tissue)   Catalase (µ moles of H~2~O~2~ oxidized/mg of protein)   Nitrite level (ng/g of wet tissue)
  ------------------ ------------------------- ------------------------------------ ------------------------------------------------------- ------------------------------------
  Cortex                                                                                                                                    
   Naïve             10.26±0.82                48.33±4.04                           2.87±0.26                                               277±21.28
   Vehicle control   25.24±1.11\*              22.91±1.36\*                         1.69±0.15\*                                             825±5.14\*
   IMP 15 mg/kg      13.05±1.10^\#^            30.84±1.15                           2.14±0.14                                               521±9.62^\#^
   AAE 25 mg/kg      19.88±0.81^\#^            21.92±2.47                           1.59±0.14                                               712.3±12.4^\#^
   AAE 50 mg/kg      15.35±2.07^\#^            25.24±1.71                           2.12±0.12                                               626.83±12.94^\#^
   AAE 100 mg/kg     10.87±0.89^\#^            35.12±3.06^\$^                       2.99±0.07^\#^                                           472±20.57^\#^
  Hippocampus                                                                                                                               
   Naïve             10.12±1.03                42.66±5.06                           2.58±0.23                                               242.66±17.17
   Vehicle control   22.33±1.56\*              21.25±1.59\*                         1.61±0.13\*                                             814.16±8.41\*
   IMP 15 mg/kg      11.73±1.11^\#^            28.45±2.15                           2±0.04                                                  529±15.68^\#^
   AAE 25 mg/kg      18.62±0.97^\#^            22.48±1.96                           1.32±0.08                                               718.2±15.12^\#^
   AAE 50 mg/kg      14.67±0.79^\#^            24.11±1.45                           1.86±0.05                                               605.33±12.31^\#^
   AAE 100 mg/kg     12.50±0.94^\#^            33.18±2.94^ψ^                        2.76±0.09^\#^                                           513±10.88^\#^

Values were expressed as mean±SEM. The significance level was considered as *P*\<0.05 (Student-Newman-Keuls test). \*As compared with Naïve, ^\#^As compared with vehicle control. Vehicle control=Saline; intraperitoneal, IMP 15=Imipramine 15 mg/kg; intraperitoneal, AAE 25, 50, and 100=*Asparagus adscendens* extract 25, 50, and 100 mg/kg; *i.p*., SEM=Standard error of mean, TBARS=Thiobarbituric acid-reactive substance, GSH=Glutathione, ^\$^As compared to AAE 25 mg/kg; ^ψ^As compared to AAE 50 mg/kg

There was a statistically significant difference in reduced GSH level in the cortical (F~5,30\]~= 15.71, *P* \< 0.0001) and hippocampal (F~5,30\]~= 8.251, *P* \< 0.0001) areas in between the groups. Student--Newman--Keuls test suggested a significant decrease in cortical and hippocampal reduced GSH levels of vehicle control as compared to naive group. However, a significant increase was observed in cortical and hippocampal reduced GSH levels of AAE-treated groups as compared to vehicle control group. There was no significant change observed in cortical and hippocampal reduced GSH levels in imipramine-treated group as compared to vehicle control group \[[Table 1](#T1){ref-type="table"}\].

One-way ANOVA showed that CAT level was significantly different in both cortical (F~5,30\]~= 19.33, *P* \< 0.0001) and hippocampal (F~5,30\]~= 12.79, *P* \< 0.0001) areas in between the groups. Student--Newman--Keuls test revealed a significant decrease in cortical and hippocampal CAT levels of vehicle control as compared to naive group. However, a significant increase in the CAT levels was elicited by the administration of AAE in both cortical and hippocampal areas as compared to vehicle control group. There was no significant change observed in cortical and hippocampal CAT levels in imipramine-treated group as compared to vehicle control group \[[Table 1](#T1){ref-type="table"}\].

One-way ANOVA showed that total nitrite levels were significantly different in both cortical (F~5,30\]~= 169.7, *P* \< 0.0001) and hippocampal (F~5,30\]~= 210.6, *P* \< 0.0001) areas in between the groups. Student--Newman--Keuls test revealed a significant increase in cortical and hippocampal total nitrite levels of vehicle control as compared to naive group. However, a significant decrease in the total nitrite levels was attenuated by the administration of AAE in both cortex and hippocampus as compared to vehicle control group. Similarly, imipramine also significantly decreased the total nitrite levels in both cortex and hippocampus as compared to vehicle control group \[[Table 1](#T1){ref-type="table"}\].

### Effect of *Asparagus adscendens* extract on serum corticosterone level {#sec3-7}

There was statistically significant difference in the serum corticosterone level (F~5,30\]~= 14.39, *P* \< 0.0001) in between the groups. Student--Newman--Keuls test showed an increase in serum corticosterone level of vehicle control as compared to naive group. However, AAE (25, 50, and 100 mg/kg) significantly decreased the serum corticosterone level in a dose-dependent manner as compared to vehicle control group \[[Figure 3](#F3){ref-type="fig"}\]. Similarly, imipramine also decreased the serum corticosterone level as compared to vehicle control group.

![Effect of *Asparagus adscendens* extract treatment on serum corticosterone levels. Values were expressed as mean ± standard error of the mean. The significance level was considered as *P*\< 0.05 (Student--Newman--Keuls test) \* = As compared with naïve; \# = As compared with vehicle control](IJPharm-51-98-g003){#F3}

Discussion {#sec1-4}
==========

This is the first attempt, to our knowledge, to scientifically screen the antidepressant effect of hydroethanolic root extract of *A. adscendens*. The results of the current study demonstrate the significant antidepressant-like effect of AAE as observed in the behavioral tests on mice showing its involvement on monoaminergic neurotransmitters, oxidative stress markers, and serum corticosterone levels.

The behavioral stress paradigms are most widely used to assess antidepressant effect because of their reliability, ease of use, sensitivity, and specificity.\[[@ref49][@ref50]\] Both TST and FST are most widely accepted behavioral tools with good predictive value for assessing pharmacological antidepressant activity, besides the limitation of assessing only monoaminergic mechanisms.\[[@ref51][@ref52]\] In both the models, animals were placed in an inescapable situation and became immobile, resembling that behavioral despair represents a condition that mimics human depression.\[[@ref53][@ref54]\] Moreover, the well-known antidepressants were found to be effective in both the models as evidenced by decreased immobility time.\[[@ref50][@ref55]\] In line with this, our data showed that treatment with AAE reduced the duration of immobility in the FST and TST, with peak effect observed at 100 mg/kg in both the models. Furthermore, the swimming and climbing time were also increased after the treatment with AAE in mice. The psychostimulant agents such as caffeine, decreases the immobility time similar to antidepressant drugs but causes the motor stimulation. Therefore, to rule out this false positive result, we had evaluated the locomotor activity in Open Field test (OFT).\[[@ref56][@ref57][@ref58]\] However, none of the test doses affect the locomotor activity. Thus, the results indicated that anti-immobility effect of AAE might not be attributed to any psychostimulant effect as evidenced in OFT.

The classic depression hypothesis of monoamines postulates that the major neurochemical process in depression is the impairment of monoamine neurotransmitter levels.\[[@ref59]\] It has been recognized as a multifactorial disease with changes in many different biochemical parameters involving not only monoamines levels, but also causing the hyperactivity of hypothalamic--pituitary--adrenal (HPA) axis along with oxidative damage by inducing an imbalance between the *in vivo* pro-oxidant and antioxidant status.\[[@ref60]\] In line to this, several human studies have shown that depression causes HPA dysfunction followed by elevated corticosterone levels and reduced monoamines levels along with some behavioral and biochemical changes that are characteristic of depression.\[[@ref61][@ref62]\] Thus, this prompted us to investigate the above factors in the current study.

Enhancement of 5-HT and NE levels in AAE-treated animals complements the observed antidepressant effect. In addition, these neurotransmitters have also involved in the expression of antidepressant effect in behavioral despair models of depression\[[@ref63][@ref64]\] as described by Detke *et al*. The antidepressant drugs enhanced swimming and climbing acts through serotonergic neurotransmission, such as fluoxetine, and catecholaminergic neurotransmission, such as desipramine,\[[@ref37]\] respectively. In the current study, our results showed enhanced swimming and climbing time in AAE-treated animals, indicating that the antidepressant-like effect might be mediated through both serotonergic and catecholaminergic neurotransmissions. The above findings were further confirmed by enhanced monoamines levels, namely, NE, DA, and 5-HT in the cortex and hippocampus of AAE-treated animals as compared to vehicle control group. Moreover, imipramine also enhanced the levels of monoamines as compared to vehicle control group. Similarly, our results are corroborated with earlier evidence which demonstrated that conventional antidepressant drugs produced their pharmacological effect through enhancement of noradrenergic, serotonergic, and/or dopaminergic neurotransmission.\[[@ref65]\] Hence, the antidepressant activity produced by AAE treatment might be due to enhanced monoaminergic levels.

In addition to monoaminergic system, a role of oxidative stress has also been reported in depression. A numerous studies have demonstrated that free radical generation increased during depression, which play an important role in the pathogenesis of depression.\[[@ref32]\] Interestingly, several medicinal plants showing antidepressant activity such as *Bacopa monniera* Wettst. (Scrophulariaceae)\[[@ref66]\] and *Withania somnifera* Dunal (Solanaceae)\[[@ref67]\] have been reported to possess antidepressant effect due to its ameliorative antioxidant activity. Moreover, *A. adscendens* has already known for its antioxidant potential.\[[@ref18]\] Thus, we evaluated the oxidative parameters in this study which might be having an ameliorative effect on depression. Based on our results, AAE significantly increased the activity of CAT and reduced GSH levels in both cortex and hippocampus. Additionally, it also showed significant reduction in the level of lipid peroxidation marker (MDA) and total nitrite levels in both cortex and hippocampus. Thus, the observed antidepressant effect of AAE might be supported by its antioxidant effect.

Hyperactivation of HPA axis is another additional pathogenic factor for depression.\[[@ref68][@ref69]\] Furthermore, several studies have been well documented for the increase in corticosterone levels in response to overactivation of HPA axis, which correlated with behavioral alterations observed in depressed patients including anxiety, fear, and other psychological alterations.\[[@ref70]\] In this study, our data suggest that AAE exerted antidepressant effect, at least in part, by downregulating the corticosterone levels, thus normalizing the HPA hyperactivity. Similarly, imipramine also decreased the corticosterone level by regulating the HPA axis hyperactivity.

Conclusion {#sec1-5}
==========

The current study has demonstrated an antidepressant-like effect of AAE by facilitating monoaminergic neurotransmission and also by regulating HPA axis along with amelioration of oxidative stress.
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